1.
Szkultecka-Dębek M, Drozd M, Wiśniewska N, Drozd K. Adverse events (AE) costs assessed in Poland based on existing Drug Programs – methodology of the project. Curr. Issues Pharm. Med. Sci. 2013;26(4):422-424. doi:10.12923/j.2084-980X/26.4/a.16